Cytodyn OTC Stock Valuation

CYDY
 Stock
  

USD 0.35  0.01  2.78%   

Do you wonder what the value of Cytodyn is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Cytodyn, is its stock price multiplied by the total number of shares outstanding, calculating Cytodyn's enterprise value requires a different approach. It uses Cytodyn's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Cytodyn seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of Cytodyn from analyzing the firm fundamentals such as Current Valuation of 317.11 M, shares owned by insiders of 8.10 %, and Return On Asset of (1.25) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Cytodyn Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Cytodyn's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Cytodyn Most Recent Valuation Data

Beta
(0.0265) 
Fiscal Year End
May
Enterprise Value
317.1 M
net Debt
32 M
accounts Payable
81.9 M
other Operating Expenses
781 K
Fairly Valued
Today 0.35
Please note that Cytodyn's price fluctuation is out of control at this time. Calculation of the real value of Cytodyn is based on 3 months time horizon. Increasing Cytodyn's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cytodyn is useful when determining the fair value of the Cytodyn otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cytodyn. Since Cytodyn is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cytodyn OTC Stock. However, Cytodyn's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
0.35
Real Value
6.95
Upside
Estimating the potential upside or downside of Cytodyn helps investors to forecast how Cytodyn otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cytodyn more accurately as focusing exclusively on Cytodyn's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
0.020.356.95
Details

Cytodyn Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Cytodyn's current stock value. Our valuation model uses many indicators to compare Cytodyn value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytodyn competition to find correlations between indicators driving Cytodyn's intrinsic value. More Info.
Cytodyn is number one stock in price to book category among related companies. It is rated third in price to earning category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cytodyn by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cytodyn's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cytodyn's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cytodyn's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cytodyn and how it compares across the competition.

About Cytodyn Valuation

The otc valuation mechanism determines the current worth of Cytodyn on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Cytodyn. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cytodyn based exclusively on its fundamental and basic technical indicators. By analyzing Cytodyn's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cytodyn's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cytodyn. We calculate exposure to Cytodyn's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytodyn's related companies.
Fiscal Year End
May
Industry
Biotechnology
Concentration
Biotechnology
Full Time Employees
23.0
Service Category
Biotechnology
Employer Id Number
83-1887078
CytoDyn Inc. operates as a clinical-stage biotechnology company. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Cytodyn operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people.
Continue to Trending Equities. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Cytodyn OTC Stock analysis

When running Cytodyn price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Please note, there is a significant difference between Cytodyn's value and its price as these two are different measures arrived at by different means. Investors typically determine Cytodyn value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytodyn's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.